Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis
Authors:
- Richy C.Y. ChenRCRichy C.Y. Chen
- Phornnop NaiyanetrPNPhornnop Naiyanetr
- Shang-An ShuSSShang-An Shu
- Jinjun WangJWJinjun Wang
- Guo-Xiang YangGYGuo-Xiang Yang
- Thomas P. KennyTKThomas P. Kenny
- Kathryn C. GuggenheimKGKathryn C. Guggenheim
- Jeffrey D. ButlerJBJeffrey D. Butler
- Christopher BowlusCBChristopher Bowlus
- Mi-Hua TaoMTMi-Hua Tao
- Mark J. KurthMKMark J. Kurth
- Aftab A. AnsariAAAftab A. Ansari
Open Access
- 26 November 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 57 (4) , 1498-1508
Abstract
Antimitochondrial antibodies (AMAs) directed against the lipoyl domain of the E2 subunit of pyruvate dehydrogenase (PDC-E2) are detected in 95% of patients with primary biliary cirrhosis (PBC) and are present before the onset of clinical disease. The recent demonstration that AMAs recognize xenobiotic modified PDC-E2 with higher titers than native PDC-E2 raises the possibility that the earliest events involved in loss of tolerance are related to xenobiotic modification. We hypothesized that reactivity to such xenobiotics would be predominantly immunoglobulin M (IgM) and using sera from a large cohort of PBC patients and controls (n = 516), we examined in detail sera reactivity against either 6,8-bis(acetylthio) octanoic acid (SAc)-conjugated bovine serum albumin (BSA), recombinant PDC-E2 (rPDC-E2) or BSA alone. Further, we also defined the relative specificity to the SAc moiety using inhibition enzyme-linked immunosorbent assay (ELISA); SAc conjugate and rPDC-E2-specific affinity-purified antibodies were also examined for antigen specificity, isotype, and crossreactivity. Reactivity to SAc conjugates is predominantly IgM; such reactivity reflects a footprint of previous xenobiotic exposure. Indeed, this observation is supported by both direct binding, crossreactivity, and inhibition studies. In both early and late-stage PBC, the predominant Ig isotype to SAc is IgM, with titers higher with advanced stage disease. We also note that there was a higher level of IgM reactivity to SAc than to rPDC-E2 in early-stage versus late-stage PBC. Interestingly, this finding is particularly significant in light of the structural similarity between SAc and the reduced form of lipoic acid, a step which is similar to the normal physiological oxidation of lipoic acid. Conclusion: Specific modifications of the disulfide bond within the lipoic-acid-conjugated PDC-E2 moiety, i.e., by an electrophilic agent renders PDC-E2 immunogenic in a genetically susceptible host.Keywords
Funding Information
- National Institutes of Health (DK39588, DK067003)
This publication has 55 references indexed in Scilit:
- Autoantigenesis: the evolution of protein modifications in autoimmune diseaseCurrent Opinion in Immunology, 2012
- Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivityJournal of Autoimmunity, 2011
- Immunoglobulin M Levels Inversely Correlate With CD40 Ligand Promoter Methylation in Patients With Primary Biliary CirrhosisHepatology, 2011
- Questions Persist: Environmental Factors in Autoimmune DiseaseEnvironmental Health Perspectives, 2011
- Autoimmune acute liver failure: Proposed clinical and histological criteriaHepatology, 2010
- The autoimmunity of primary biliary cirrhosis and the clonal selection theoryImmunology & Cell Biology, 2010
- Biliary Apotopes and Anti-Mitochondrial Antibodies Activate Innate Immune Responses in Primary Biliary Cirrhosis†Hepatology, 2010
- Apotopes and the biliary specificity of primary biliary cirrhosis†Hepatology, 2009
- The X and why of xenobiotics in primary biliary cirrhosisJournal of Autoimmunity, 2007
- Analysis of parotid glands of primary Sjögren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targetsClinical and Experimental Immunology, 2006